Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magd Zakaria

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis and Related Disorders|May 27, 2015
Smoke and mirrors: Limited value of relative risk reductions for assessing the benefits of disease-modifying therapies for multiple sclerosisMagd Zakaria
Frontiers in Neurology|December 13, 2023
Adherence to subcutaneous interferon beta-1a treatment among patients with relapsing multiple sclerosis: the MAIN-MS studyRaed Al-Roughani, Magd Zakaria, Edward J Cupler, et al.
Cerebrovascular Diseases Extra|December 5, 2021
Changing the Landscape of Stroke in EgyptHany Aref, Magd Zakaria, Hossam Shokri, et al.
Multiple Sclerosis and Related Disorders|March 3, 2019
Vitamin D and body mass index in Egyptian multiple sclerosis patientsDina Zamzam, Mohamed Foad, Mahmoud Swelam, et al.
Multiple Sclerosis and Related Disorders|September 3, 2021
MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosisBassem I Yamout, Magd Zakaria, Jihad Inshasi, et al.
Multiple Sclerosis and Related Disorders|January 24, 2025
Development and validation of a scoring system for predicting disease activity in treatment-naïve patients with relapsing-remitting multiple sclerosisMagd Zakaria, Nevin Mohieldin Shalaby, Farouk Talaat, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 3, 2021
The Clinical Characteristics of Patients with Pre-Existing Leukoaraiosis Compared to Those Without Leukoaraiosis in Acute Ischemic StrokeSherine Farag, Fatma Fathalla Kenawy, Hossam M Shokri, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 18, 2022
Cognitive impairment in asymptomatic cerebral arterial stenosis: a P300 studyNevine El Nahas, Amr Zaki, Magd Zakaria, et al.
European Journal of Neurology|April 15, 2025
Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European NeurologistsThomas Berger, Markus Zeitlinger, Veronica Popescu, et al.
The International Journal of Neuroscience|December 29, 2016
Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?Maurice Dahdaleh, Raed Alroughani, Mohammed Aljumah, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis and Related Disorders|May 27, 2015
Smoke and mirrors: Limited value of relative risk reductions for assessing the benefits of disease-modifying therapies for multiple sclerosisMagd Zakaria
Frontiers in Neurology|December 13, 2023
Adherence to subcutaneous interferon beta-1a treatment among patients with relapsing multiple sclerosis: the MAIN-MS studyRaed Al-Roughani, Magd Zakaria, Edward J Cupler, et al.
Cerebrovascular Diseases Extra|December 5, 2021
Changing the Landscape of Stroke in EgyptHany Aref, Magd Zakaria, Hossam Shokri, et al.
Multiple Sclerosis and Related Disorders|March 3, 2019
Vitamin D and body mass index in Egyptian multiple sclerosis patientsDina Zamzam, Mohamed Foad, Mahmoud Swelam, et al.
Multiple Sclerosis and Related Disorders|September 3, 2021
MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosisBassem I Yamout, Magd Zakaria, Jihad Inshasi, et al.
Multiple Sclerosis and Related Disorders|January 24, 2025
Development and validation of a scoring system for predicting disease activity in treatment-naïve patients with relapsing-remitting multiple sclerosisMagd Zakaria, Nevin Mohieldin Shalaby, Farouk Talaat, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 3, 2021
The Clinical Characteristics of Patients with Pre-Existing Leukoaraiosis Compared to Those Without Leukoaraiosis in Acute Ischemic StrokeSherine Farag, Fatma Fathalla Kenawy, Hossam M Shokri, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 18, 2022
Cognitive impairment in asymptomatic cerebral arterial stenosis: a P300 studyNevine El Nahas, Amr Zaki, Magd Zakaria, et al.
European Journal of Neurology|April 15, 2025
Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European NeurologistsThomas Berger, Markus Zeitlinger, Veronica Popescu, et al.
The International Journal of Neuroscience|December 29, 2016
Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?Maurice Dahdaleh, Raed Alroughani, Mohammed Aljumah, et al.
Pageof 3